Endo Hits Impax With 3rd Suit Over Painkiller

Law360, New York (July 29, 2008, 12:00 AM EDT) -- Endo Pharmaceuticals Holdings Inc. and Penwest Pharmaceuticals Co. have slapped Impax Laboratories Inc. with a third patent infringement suit over the company's attempts to manufacture its generic version of pain treatment Opana ER.

The latest suit, filed Friday in the U.S. District Court for the District of Delaware, responds to a notice Impax sent the other two companies on June 13, informing them that it had amended its abbreviated new drug application to include three new dosage sizes of the generic painkiller.

On March 3, Endo...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.